My guess is that PBI 4050 will treat cystic fibrosisWhy? First: PBI 4050 is intented to treat problems related to diabeties, and almost 100% of those with cystic Fibrosis will have diabeties during there lives because of some pancreatic problems related to there treatment. Second: it was already mentioned that PBI 4050 may have a positive effect on the respiratory system. And the main problem with Cystic Fibrosis is respiratory. Third: Cystic Fibrosis is a rare disease but it's remarkably highly present in the Canadian population more than any other geographic location. It's estimated that 1 enfant of each 3600 in Canada has the Cystic Fibrosis. Fourth: the curre t treatment of Cystic Fibrosis will give a median age of 50.9 years for the patient... But the patient will suffer all the long and it'll cost fortunes to the health system. For those reasons i think that our new indication will be the Cystic Fibrosis. World populatio Of Cystic Fibrosis patients will be arrpund 90 000 with about half of it in Canada. If we say 10 000 a year for the treatment... We are talking about 900 M$ worth for this indication alone... I hope i am right... I know poeple that they have this disease and it's awfull.... Just an observation. GLTA Mimi